Gsk Share Discussion Threads

[supermarky] 10/1/2022 11:52

gsk not exactly joining the party this year so far.

[geckotheglorious] 07/1/2022 12:38

908 Devices (NASDAQ:MASS) announced that GlaxoSmithKline (NYSE:GSK) has purchased an additional REBEL cell culture media analyzer.

GSK will now have a total of five REBEL analyzers being used by its biologics and vaccine process development teams.

REBEL is the first miniature CE-MS-based analyzer that enables biopharma researchers to accelerate process development cycles and maximize bioreactor utilization by running media analysis at-line.

"We are pleased that GSK has once again chosen our REBEL desktop device as part of its process development efforts to bring promising therapeutics to market," says Dr. Kevin J. Knopp, CEO and co-founder of 908 Devices.

[tradermichael] 07/1/2022 12:28

Disappointing first week's trading for what is supposed to be the 'year' for GSK .... ;0

[mattboxy] 06/1/2022 15:56

My point was I'm not really clear what your question is. What exactly did you mean by china of pharmaceuticals? Is it referring to a human rights angle?

[jonjoneil] 06/1/2022 13:00

my question was a bit deeper than that

[mattboxy] 06/1/2022 12:01

What making lots of cheap plastic drugs? That's a weird question!

[time for common sense] 06/1/2022 11:08

Hope you will get it this time. https://mobile.twitter.com/cryptotraveler/status/1478387607419727877

[jonjoneil] 06/1/2022 10:50

Is Pfizer becoming the China of pharmaceuticals? Discuss..

[time for common sense] 06/1/2022 09:28

From another forum. 5 Jan 2022 - UK nurse speaking about mandates; more sense than 99% of the bells at westminster. 2 mins long.Https://www.youtube.com/watch?v=ZcALmrqPaZg

[spyder] 04/1/2022 16:30

Hopefully it won't take that long rikky! ;-)

[rikky72] 04/1/2022 16:07

I've just sold some so prediction is now clearly £20 by summer :)

[eaaxs06] 04/1/2022 16:06

It was down over 1% in America yesterday, when the UK markets were closed, so it's just playing catch up.

Good luck for 2022 everyone, Sid.

[jonjoneil] 04/1/2022 15:56

I can't find any info as to why it's so down against the market. Anyone got a clue?
Hardly down at all in NY

[supermarky] 04/1/2022 12:04

i am keeping an eye and looking to re purchase on weakness. Took the decision to sell all my gsk just before Christmas.

[tradermichael] 04/1/2022 10:41

Happy 2022 to all.

Yes spoole5, GSK showing its true 'defensive' qualities.

[spoole5] 04/1/2022 09:25

Great start to the year for everything except gsk!

[philanderer] 03/1/2022 20:00

1619p equivalent a couple of minutes ago.

[jonjoneil] 03/1/2022 16:16

down equivalent of 20p in NY, against the market. Not a good start to the year

[watfordhornet] 31/12/2021 11:27

Guess will depend whether she is ousted or not.let's hope so so we can have a good 2022

[jonjoneil] 31/12/2021 10:48

trying hard to close below 16

hope '22 is the turning point Emma has promised

[tradermichael] 31/12/2021 08:18

IN @ 1606.2 ...... ;0)

[davebowler] 30/12/2021 15:18

..........Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces the launch of the world's first generic version of Pfizer's COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged for oral use) which was granted emergency use authorization (EUA) by the US FDA on 22 December 2021. Directorate General of Drug Administration (DGDA), Bangladesh, has today granted EUA for the oral antiviral drug to treat mild-to-moderate COVID-19 in adults and children of 12 years and above. This novel antiviral pill showed almost 90% efficacy in preventing hospitali z ations and deaths in high-risk patients, and recent data from Pfizer suggests the drug retains its effectiveness against the fast-spreading Omicron variant of the coronavirus. Beximco Pharma will market this product under the brand name Bexovid, initially in Bangladesh.

[geckotheglorious] 24/12/2021 13:43

Antidepressant linked to suicide risk in adults
Britain's bestselling antidepressant, Seroxat, can cause adults as well as children to become suicidal, according to the manufacturer, GlaxoSmithKline.


(*2006)

GSK shifts away from antidepressants

(*2010)

Suspect they do not now Jon.